Where the Money Goes

You are here

ALSF Childhood Cancer Research Grants

With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.

Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.

You can learn about ALSF's grant review process here.

Support This Research

Jump to search filters

ALSF Funded Research Projects

Project Title	Institution / Principal Investigator(s)	Grant Type	Year	State
Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy	University of North Carolina / Timothy Gershon, MD, PhD	Innovation Grants	2015	North Carolina
Transcriptional Effectors of Activated RAS Signaling in Juvenile Myelomonocytic Leukemia	Boston Children’s Hospital / Alan Cantor, MD, PhD	Innovation Grants	2015	Massachusetts
Small Molecule Inhibitors of ERG for Pediatric Leukemia and Sarcoma	University of Virginia, School of Medicine / John Bushweller, PhD	Innovation Grants	2015	Virginia
Regulation of Tumor Debris Mediated Inflammation as a Therapeutic Modality in Medulloblastoma	Dana-Farber Cancer Institute / Mark Kieran, MD, PhD & Dipak Panigrahy, MD	Innovation Grants	2015	Massachusetts
High-dimensional Biochemical CyTOF Analysis of Pediatric T cell Leukemias	University of California San Francisco / Jeroen Roose, PhD	Innovation Grants	2015	California
Identifying Epigenetic Mechanisms Impacting Neuroblastoma Genome Stability and Drug Response	Massachusetts General Hospital / Johnathan Whetstine, PhD	Innovation Grants	2015	Massachusetts
Identifying how Pre-existing Anti-Therapeutic Antibodies (PATA) are Associated with Better Outcome in a Clinical Trial of ADCC-inducing Anti-GD2 mAb	University of Wisconsin - Madison / Paul Sondel, MD, PhD	Innovation Grants	2015	Wisconsin
Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma	Virginia Commonwealth University / Anthony Faber, MD & Yael Mosse, MD (CHOP)	Innovation Grants	2015	Virginia
CAMKV as a Target for Immunotherapy in MYCN-Amplified Neuroblastoma	Children’s Hospital of Philadelphia / Robyn Sussman, PhD	Young Investigator Grants	2015	Pennsylvania
Zebrafish Modeling of PAX3-FOXO1 Driven Rhabdomyosarcoma	University of Texas Southwestern Medical Center / Genevieve Kendall, PhD	Young Investigator Grants	2015	Texas

Pages